Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TP-38 in Recurrent Glioblastoma Multiforme
NCT00104091Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2004
- Primary completion
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes, Immunotoxins
01
Overview
A Phase 2 trial of tp-38 in glioblastoma multiforme (GBM), sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2004; status: completed.
02
Drugs
tp-38
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00104091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104091.